Streetbeat News

Analyst Ratings

NNOX

Cantor Fitzgerald analyst Ross Osborn reiterated an Overweight rating on Nano X Imaging (NNOX) and maintained an $18 price target.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 2:24 pm

NVO

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Novo Nordisk (NYSE:NVO) and maintained a $140 price target.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 2:19 pm

ALNY

Cantor Fitzgerald analyst Olivia Brayer reiterated a Neutral rating on Alnylam Pharmaceuticals (NASDAQ:ALNY) and maintained a $165 price target.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 2:17 pm

SRPT

Cantor Fitzgerald analyst Kristen Kluska has reiterated a Neutral rating on Sarepta Therapeutics (NASDAQ:SRPT) and maintained a $128 price target.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 2:15 pm

RARE

Cantor Fitzgerald analyst Kristen Kluska reiterated an Overweight rating on Ultragenyx Pharmaceutical (NASDAQ:RARE) and maintained a $114 price target.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 2:14 pm

UDMY

Cantor Fitzgerald analyst Brett Knoblauch reiterated an Overweight rating on Udemy (UDMY) and maintained a $20 price target. This reaffirms the firm's positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 2:12 pm

FROG

Cantor Fitzgerald analyst Yi Fu Lee has maintained an Overweight rating on JFrog (NASDAQ:FROG) and increased the price target from $40 to $45.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 2:03 pm

BTCUSD

CSCO

ETHUSD

LMT

PFE

Cryptocurrencies surge with Bitcoin's market cap surpassing $1 trillion, potentially hitting $60K. US markets see mixed movements, with Cisco issuing a weak outlook. Global politics and economy updates include sanctions on Russia and BRICS nations challenging G7 dominance. Tech highlights include Uber's price target boost and Apple's AI chip advancements. Electric Vehicle sector notes Tesla's market strategies and challenges. New York City sues major social platforms over mental health concerns. Pfizer settles a lawsuit, and Lockheed Martin faces budget cuts on F-35 orders.

Portfolio Pulse from Akanksha Bakshi

February 15, 2024 | 2:02 pm

MLM

Martin Marietta Materials (NYSE:MLM) received mixed analyst ratings over the past three months, with an updated average 12-month price target of $589.5, marking a 13.0% increase from the previous target. The company's financial performance shows strong revenue growth and net margin but faces challenges in ROE, ROA, and debt management. Analysts from Truist Securities, Raymond James, Morgan Stanley, and Stifel have adjusted their ratings and price targets, reflecting a positive outlook on MLM's market position and performance.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 2:01 pm

SITE

SiteOne Landscape Supply (NYSE:SITE) has received mixed analyst ratings over the past quarter, with a recent shift towards more bullish sentiments. The average 12-month price target for SITE has been raised to $161.4, indicating a 14.67% increase from the previous target of $140.75. Analysts from Barclays, Truist Securities, and Stifel have updated their ratings and price targets, reflecting changes in market conditions and company performance. Despite challenges in market capitalization, revenue growth, net margin, and ROE, SITE's ROA and conservative debt management are positive indicators.

Portfolio Pulse from Benzinga Insights

February 15, 2024 | 2:01 pm